JP2002538150A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002538150A5 JP2002538150A5 JP2000602224A JP2000602224A JP2002538150A5 JP 2002538150 A5 JP2002538150 A5 JP 2002538150A5 JP 2000602224 A JP2000602224 A JP 2000602224A JP 2000602224 A JP2000602224 A JP 2000602224A JP 2002538150 A5 JP2002538150 A5 JP 2002538150A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- phenyl
- substituted
- conh
- ocf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 48
- -1 biphenylyl Chemical group 0.000 description 13
- 229910052731 fluorine Inorganic materials 0.000 description 13
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 10
- 125000000217 alkyl group Chemical group 0.000 description 7
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 6
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 6
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 5
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 5
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 4
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 4
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 4
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 4
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 4
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 4
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 4
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 4
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000011737 fluorine Substances 0.000 description 4
- 125000001153 fluoro group Chemical group F* 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 125000002541 furyl group Chemical group 0.000 description 3
- 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 description 3
- 125000004531 indol-5-yl group Chemical group [H]N1C([H])=C([H])C2=C([H])C(*)=C([H])C([H])=C12 0.000 description 3
- 125000001624 naphthyl group Chemical group 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 125000001544 thienyl group Chemical group 0.000 description 3
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 description 2
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 description 2
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical group C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
- 125000001506 1,2,3-triazol-5-yl group Chemical group [H]N1N=NC([H])=C1[*] 0.000 description 1
- 125000001305 1,2,4-triazol-3-yl group Chemical group [H]N1N=C([*])N=C1[H] 0.000 description 1
- 125000001414 1,2,4-triazol-5-yl group Chemical group [H]N1N=C([H])N=C1[*] 0.000 description 1
- 125000004317 1,3,5-triazin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=N1 0.000 description 1
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical compound [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 description 1
- 125000004539 5-benzimidazolyl group Chemical group N1=CNC2=C1C=CC(=C2)* 0.000 description 1
- CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001539 anorectic effect Effects 0.000 description 1
- 125000004190 benzothiazol-2-yl group Chemical group [H]C1=C([H])C([H])=C2N=C(*)SC2=C1[H] 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 125000005322 morpholin-1-yl group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000005545 phthalimidyl group Chemical group 0.000 description 1
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 1
- 125000004526 pyridazin-2-yl group Chemical group N1N(C=CC=C1)* 0.000 description 1
- 125000002206 pyridazin-3-yl group Chemical group [H]C1=C([H])C([H])=C(*)N=N1 0.000 description 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 description 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004299 tetrazol-5-yl group Chemical group [H]N1N=NC(*)=N1 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19908533.1 | 1999-02-26 | ||
| DE19908533A DE19908533A1 (de) | 1999-02-26 | 1999-02-26 | Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen |
| PCT/EP2000/000927 WO2000051997A1 (de) | 1999-02-26 | 2000-02-05 | Polycyclische thiazol-systeme und ihre verwendung als anorektika |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002538150A JP2002538150A (ja) | 2002-11-12 |
| JP2002538150A5 true JP2002538150A5 (https=) | 2007-03-29 |
| JP4728485B2 JP4728485B2 (ja) | 2011-07-20 |
Family
ID=7899078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000602224A Expired - Fee Related JP4728485B2 (ja) | 1999-02-26 | 2000-02-05 | 多環式チアゾール系および食欲抑制剤としてのその使用 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6187801B1 (https=) |
| EP (1) | EP1183247B1 (https=) |
| JP (1) | JP4728485B2 (https=) |
| KR (1) | KR20020000545A (https=) |
| CN (1) | CN1149205C (https=) |
| AT (1) | ATE296295T1 (https=) |
| AU (1) | AU762802B2 (https=) |
| BR (1) | BR0008511A (https=) |
| CA (1) | CA2364903A1 (https=) |
| CO (1) | CO5180595A1 (https=) |
| DE (2) | DE19908533A1 (https=) |
| DK (1) | DK1183247T3 (https=) |
| ES (1) | ES2241574T3 (https=) |
| HK (1) | HK1042300B (https=) |
| MY (1) | MY133195A (https=) |
| PT (1) | PT1183247E (https=) |
| TW (1) | TW593294B (https=) |
| WO (1) | WO2000051997A1 (https=) |
| ZA (1) | ZA200106440B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19908535A1 (de) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| NZ520981A (en) * | 2000-02-26 | 2004-08-27 | Aventis Pharma Gmbh | 8,8a-dihydro-indeno[1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament |
| DE10142663B4 (de) * | 2001-08-31 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | C2-Disubstituierte Indan-1-ol-Systeme |
| KR100712171B1 (ko) * | 2004-09-17 | 2007-05-02 | 김진우 | 폐타이어를 이용한 조립식 배관블록 |
| MX2010010659A (es) * | 2008-03-31 | 2010-10-26 | Genentech Inc | Compuestos de benzopirano y benzoxepina, inhibidores de fosfoinoinositida 3-cinasas y metodos para utilizarlos. |
| US8263633B2 (en) | 2009-09-28 | 2012-09-11 | F. Hoffman-La Roche Ag | Benzoxepin PI3K inhibitor compounds and methods of use |
| MY160064A (en) | 2009-09-28 | 2017-02-15 | Hoffmann La Roche | Benzoxazepin pi3k inhibitor compounds and methods of use |
| US9090628B2 (en) | 2011-03-21 | 2015-07-28 | Genentech, Inc. | Benzoxazepin compounds selective for PI3K P110 delta and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2640358A1 (de) * | 1976-09-08 | 1978-03-16 | Hoechst Ag | Thiazolidinderivate und verfahren zu ihrer herstellung |
| EP0749966A4 (en) * | 1994-03-11 | 1997-07-02 | Yamanouchi Pharma Co Ltd | 5-HT 3 RECEPTOR AGONIST, NEW THIAZOLE DERIVATIVE AND INTERMEDIATE FOR OBTAINING IT |
| JPH1179993A (ja) * | 1997-09-05 | 1999-03-23 | Sumitomo Pharmaceut Co Ltd | 免疫抑制剤 |
| DE19831878C2 (de) * | 1998-07-17 | 2001-05-17 | Aventis Pharma Gmbh | Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE19908535A1 (de) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
-
1999
- 1999-02-26 DE DE19908533A patent/DE19908533A1/de not_active Withdrawn
-
2000
- 2000-02-05 EP EP00902658A patent/EP1183247B1/de not_active Expired - Lifetime
- 2000-02-05 PT PT00902658T patent/PT1183247E/pt unknown
- 2000-02-05 CA CA002364903A patent/CA2364903A1/en not_active Abandoned
- 2000-02-05 JP JP2000602224A patent/JP4728485B2/ja not_active Expired - Fee Related
- 2000-02-05 KR KR1020017010874A patent/KR20020000545A/ko not_active Ceased
- 2000-02-05 DK DK00902658T patent/DK1183247T3/da active
- 2000-02-05 ES ES00902658T patent/ES2241574T3/es not_active Expired - Lifetime
- 2000-02-05 CN CNB008042365A patent/CN1149205C/zh not_active Expired - Fee Related
- 2000-02-05 HK HK02104057.0A patent/HK1042300B/zh not_active IP Right Cessation
- 2000-02-05 WO PCT/EP2000/000927 patent/WO2000051997A1/de not_active Ceased
- 2000-02-05 AT AT00902658T patent/ATE296295T1/de not_active IP Right Cessation
- 2000-02-05 AU AU24416/00A patent/AU762802B2/en not_active Ceased
- 2000-02-05 DE DE50010403T patent/DE50010403D1/de not_active Expired - Lifetime
- 2000-02-05 BR BR0008511-1A patent/BR0008511A/pt not_active IP Right Cessation
- 2000-02-10 US US09/501,210 patent/US6187801B1/en not_active Expired - Lifetime
- 2000-02-21 CO CO00011822A patent/CO5180595A1/es not_active Application Discontinuation
- 2000-02-25 MY MYPI20000739A patent/MY133195A/en unknown
- 2000-03-20 TW TW089103194A patent/TW593294B/zh not_active IP Right Cessation
-
2001
- 2001-08-08 ZA ZA200106440A patent/ZA200106440B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004532209A5 (https=) | ||
| JP2002543183A5 (https=) | ||
| RU2420522C2 (ru) | Новый класс ингибиторов гистондеацетилаз | |
| JP2002538150A5 (https=) | ||
| CO5190698A1 (es) | Nuevos derivados de sulfonil-carboxamida, procedimientos para su preparacion y sus utilizacion como medicamentos | |
| JP2007518682A5 (https=) | ||
| JP2004518725A5 (https=) | ||
| BRPI0114870B8 (pt) | uso de 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il)pirimidin-2-amino)fenil]-benzamida para a fabricação de composições farmacêuticas para tratamento de tumores estromais gastrointestinais | |
| JP2001526218A5 (https=) | ||
| JP2005519908A5 (https=) | ||
| RU2003131964A (ru) | Производные 4-(фенил-пиперазинил-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств | |
| JP2005508293A5 (https=) | ||
| JP2002053555A5 (https=) | ||
| TR200103353T2 (tr) | Bir füzyonlu heterosiklik bileşimin hidroklorid tuzu. | |
| JP2003502367A5 (https=) | ||
| JP2002538148A5 (https=) | ||
| JP2002506864A5 (https=) | ||
| JP2002526530A5 (https=) | ||
| JP2004506721A5 (https=) | ||
| JP2007515467A5 (https=) | ||
| JP2000264961A5 (https=) | ||
| JP2002514623A5 (https=) | ||
| JP2005529869A5 (https=) | ||
| JP2003516994A5 (https=) | ||
| RU2002107996A (ru) | Применение бис-сульфонамидов для получения медикаментов для профилактики или лечения гиперлипидемии |